Cognitive Behavioral Play Therapy for Children with Epilepsy
Official title: The Effects of Cognitive Behavioral Play Intervention on the Quality of Life of Children With Childhood-onset Epileptic Syndromes."
Run by IRCCS National Neurological Institute "C. Mondino" Foundation · NCT06813612 · Data updated 2026-11-12
This study is testing if Cognitive Behavioral Play Therapy can help improve the quality of life for children aged 6 to 10 with epilepsy compared to regular free play.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years to 10 Years |
| Sex | All |
| Enrollment | 52 (estimated) |
| Sponsor | IRCCS National Neurological Institute "C. Mondino" Foundation Academic / other |
| Locations | 1 site (Pavia) |
| Status | Recruiting |
| Started | October 7, 2024 |
| Main results expected | October 2025 |
| Study ends | October 2026 |
| Registry record updated | February 7, 2025 |
| Trial ID | NCT06813612 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 6 to 10 years diagnosed with specific types of epilepsy.
✕Probably not a fit
Children with epilepsy who also have cognitive disabilities or significant sensory impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of Cognitive Behavioral Play Therapy (CBPT) in improving the quality of life for children aged 6 to 10 years diagnosed with various types of epilepsy. Participants will be randomly assigned to either the CBPT intervention group or a control group engaging in free play. The study will assess behaviors, coping strategies, positive thinking, problem-solving skills, and overall quality of life before and after the intervention. The goal is to determine if CBPT offers greater benefits compared to free play in a hospital setting.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance the emotional and psychological well-being of children with epilepsy.
How similar studies have gone: Previous studies have shown promise for play-based interventions in pediatric populations, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
For the purposes of the study, children aged between 6 and 10 years, of both sexes, will be recruited. \- inclusion criteria Children diagnosed with the following types of epilepsy will be included: childhood self-limiting focal epilepsy (SeLFE); childhood absence epilepsy (CAE); self-limiting centrotemporal paroxysmal epilepsy (SeLECTS); self-limiting epilepsy with autonomic seizures (SeLEAS); childhood occipital epilepsy (COVE); photosensitive occipital lobe epilepsy (POLE). Exclusion criteria: * Children with epilepsy in comorbidity with cognitive disabilities (the relevant cognitive disabilities must be specified with IQ scores) * reduced visual or expressive hearing acuity (visually impaired or deaf) will be excluded.
Where it's running
-
Child Neuropsichiatry
Pavia, Italy Recruiting
Study contacts
- Principal investigator: martina paola p zanaboni, psy — IRCCS Mondino Foundation
- Study coordinator: Valentina De Giorgis, MD PhD
- Email: valentina.degiorgis@mondino.it
- Phone: 0382380289
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sleep and Music for Kids with Epilepsy
This trial tests if a music-based program can improve sleep and health for children with epilepsy and their parents.
-
Registry and natural history of epilepsy-dyskinesia syndromes
This registry will collect health data and biological samples from people of all ages who have a genetic diagnosis of epilepsy-dyskinesia syndromes to see how their genes relate to their movement and seizure symptoms over time.
-
Understanding epilepsy-dyskinesia syndromes in children
This study is trying to learn more about epilepsy-dyskinesia syndromes in children by gathering information from different countries to see how these movement and seizure disorders are related.
-
RAP-219 long-acting injectable safety and PK study in healthy adults
This early study tests RAP-219-LAI in healthy adults to see how it behaves in the body and whether it is safe and tolerable.
-
Why People with Epilepsy Get More Infections
This study tests whether anti-seizure medicines affect immune function and infection risk in people with epilepsy.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.